Glaxosmithkline Plc (GSK) Recent Earnings
Glaxosmithkline Plc (GSK) reported 1st Quarter March 2019 earnings of $0.79 per share on revenue of $10.0 billion. The consensus earnings estimate was $0.66 per share on revenue of $10.0 billion. Revenue fell 0.7% compared to the same quarter a year ago.
GlaxoSmithKline PLC incorporated in United Kingdom. The Company creates, discoveres, develops, manufactures and markets pharmaceutical products including vaccines, over-the-counter (OTC) medicines and health-related consumer products.